-
Article
Open AccessDoes acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Cannabidiol (CBD) is widely used and believed to be non-intoxicating, lacking acute performance effects (e.g., non-impairing). However, a synthesis of data has not evaluated this. This meta-analysis synthesize...
-
Chapter
Cannabinoid-Related Adverse Events and Impairment
In addition to therapeutic benefits, cannabis also causes cognitive and psychomotor impairment in some individuals. Common acute adverse events can be cannabinoid-specific, such as those related to THC (e.g., ...
-
Chapter
Cannabinoid-Based Medicines: Patient Safety Considerations
Cannabis education is an important step toward mitigating risks and promoting patient safety. It is important for healthcare providers to understand the considerations, precautions, relative contraindications,...
-
Chapter
Product Safety and Quality Control
It is imperative both healthcare providers and patients are educated on all aspects of cannabis treatment, including product safety and quality control. There are a number of quality control variables to consi...
-
Chapter
Cannabinoid-Based Medicines: Dosing, Titration & Monitoring
Variations in cannabis formulations and methods of administration influence dosing, titration, and monitoring methodology. Smoking/vaporization, oral, oromucosal, and topical routes of administration each have...
